Top 10 Medical Affairs Services Providers in Apac - 2025
What was once the realm of futuristic speculation—predicting disease before symptoms appear or tailoring treatments down to the molecular level—is now becoming routine in APAC’s most advanced healthcare systems. In disease prediction and genome analysis, AI and ML are being woven into multiomics platforms to identify health risks and therapeutic responses with remarkable precision. As whole genome sequencing becomes more accessible, researchers and clinicians alike are embracing tools like single-cell analysis and spatial transcriptomics to uncover the nuances of disease progression and inform early personalized interventions.
This momentum extends into the broader life sciences ecosystem, particularly within clinical research and medical affairs services. Decentralized clinical trials, once a niche response to pandemic-era disruptions, have now matured into mainstream practice—boosted by wearable tech, telehealth platforms and AI-enabled patient recruitment systems. In parallel, medical affairs teams are leveraging real-world evidence and automated analytics to transition from traditional support roles to strategic functions that shape treatment landscapes.
Driven by these trends, the APAC region's Life Sciences and Healthcare Industry is projected to grow at a CAGR of approximately 8.1 percent to 10.6 percent.
The magazine features a thought leadership article from Dr. Israfil Merican, MD, MHM, Vice President, Head of Biopharma and Patient Access, Pharmaniaga Berhad, who emphasizes the need for halal-certified medicines to bridge therapeutic gaps and improve healthcare for Muslim patients. It also features an article from Ken Lee, General Manager and Region Head of Clinical Development, Asia Pacific at Syneos Health, who sheds light on the importance of human factors in driving efficiency in clinical development.
We also feature the stories of life sciences and healthcare companies delivering solutions crucial to driving innovation. One of them is MEDIZEN HUMANCARE, Korea’s first and only genome analysis company that has designed a customized gene chip for disease occurrence prediction specific to ethnicity and country.
In this edition featuring Disease Prediction and Genome Analysis Company of the Year in APAC 2025, Best Clinical Research & Consulting Services in APAC 2025 and Top Medical Affairs Services Providers in APAC 2025, we hope you find the right partner to meet your organization's needs.
Nominate a Company
Usually, the qualified subscribers of our magazine nominate companies with whom they have collaborated and experienced exceptional results to be in this list. Did a company you recently worked with give you stellar results and ROI? Did it turn out to be one you would wholeheartedly recommend to peers? Or do you know of such an outstanding company through your network? Please fill in the details below and nominate them to be featured here.
Top 10 Medical Affairs Services Providers in Apac
